Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Balmex AdultAdvantage** is a commercially marketed over-the-counter topical skin-protectant cream from CrossingWell for incontinence-associated skin irritation. Its active ingredient, zinc oxide 11.3%, forms a physical moisture barrier that helps protect chafed skin, seal out wetness, and reduce irritation from bladder leakage. The formulation also contains vitamin E and botanical ingredients and is marketed with Skin Shield technology, intended to neutralize or block irritants associated with incontinence-related moisture exposure. It is designed for easy topical application and removal on sensitive or compromised skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Balmex AdultAdvantage (Randob Labs).